Inglés

The subject sample mapping data table includes a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. The data table also includes sample use.

6 formularios  
  1. StudyEvent: SEV1
    1. Eligibility Criteria
    2. The subject consent data table contains subject IDs, consent group information, and affection status for estrogen receptor positive (ER+) breast cancer.
    3. The subject sample mapping data table includes a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. The data table also includes sample use.
    4. The subject phenotype data table includes age of enrollment (n=1 variable), tumor pathology (n=10 variables; baseline breast cancer luminal subtype, tumor shape, grade, maximum dimension, number of positive nodes, pathological tumor and node stage, and general comments), PEPI RFS score (n=2 variables), WHO clinical response (n=1 variable) and breast cancer biomarkers (n=15 variables; ER+, Ki-67, and Her2).
    5. The sample attributes data table includes sample type, body site where sample was extracted, sample analyte type, histological type, and time of tumor sample collection.
    6. The pre- and post-subject phenotype data table includes age, sequence of events (n=9 variables; event and recurrence of event, adverse event, follow-up time, survival status, and cause of death), surgical status (n=2 variables), tumor pathology (n=6 variables; baseline tumor type and grade, number of positive nodes, node and tumor stage, and tumor dimension), PEPI RFS score (n=2 variables), and breast cancer biomarkers (n=6 variables; Allred ER+ score and Ki-67).
pht002594
Descripción

pht002594

De-identified Subject ID
Descripción

SubjID

Tipo de datos

string

Alias
UMLS CUI [1,1]
C4684638
UMLS CUI [1,2]
C2348585
De-identified Sample ID
Descripción

SampID

Tipo de datos

string

Alias
UMLS CUI [1,1]
C4684638
UMLS CUI [1,2]
C1299222
Sample Use
Descripción

SAMPLE_USE

Tipo de datos

string

Alias
UMLS CUI [1,1]
C1524063
UMLS CUI [1,2]
C0370003
Volver a la parte superior de la página

Similar models

The subject sample mapping data table includes a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. The data table also includes sample use.

6 formularios
  1. StudyEvent: SEV1
    1. Eligibility Criteria
    2. The subject consent data table contains subject IDs, consent group information, and affection status for estrogen receptor positive (ER+) breast cancer.
    3. The subject sample mapping data table includes a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. The data table also includes sample use.
    4. The subject phenotype data table includes age of enrollment (n=1 variable), tumor pathology (n=10 variables; baseline breast cancer luminal subtype, tumor shape, grade, maximum dimension, number of positive nodes, pathological tumor and node stage, and general comments), PEPI RFS score (n=2 variables), WHO clinical response (n=1 variable) and breast cancer biomarkers (n=15 variables; ER+, Ki-67, and Her2).
    5. The sample attributes data table includes sample type, body site where sample was extracted, sample analyte type, histological type, and time of tumor sample collection.
    6. The pre- and post-subject phenotype data table includes age, sequence of events (n=9 variables; event and recurrence of event, adverse event, follow-up time, survival status, and cause of death), surgical status (n=2 variables), tumor pathology (n=6 variables; baseline tumor type and grade, number of positive nodes, node and tumor stage, and tumor dimension), PEPI RFS score (n=2 variables), and breast cancer biomarkers (n=6 variables; Allred ER+ score and Ki-67).
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
pht002594
SubjID
Item
De-identified Subject ID
string
C4684638 (UMLS CUI [1,1])
C2348585 (UMLS CUI [1,2])
SampID
Item
De-identified Sample ID
string
C4684638 (UMLS CUI [1,1])
C1299222 (UMLS CUI [1,2])
SAMPLE_USE
Item
Sample Use
string
C1524063 (UMLS CUI [1,1])
C0370003 (UMLS CUI [1,2])
Volver a la parte superior de la página